Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETERNITY: Ethanol-Enoxaparin Lock Solution for Catheter Infections
NCT03083184Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2018
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethanol, enoxaparin in Catheter-related infection (CRI), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Feb 2018; status: recruiting.
02
Drugs
ethanolenoxaparin
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT03083184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03083184.